Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1–Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor-Reference-Cited by-同舟云学术

Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1–Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor

Published:2019-02 Issue:2 Volume:48 Page:281-291
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Takeuchi Taijiro,Mizuno Shugo,Murata Yasuhiro,Hayasaki Aoi,Kishiwada Masashi,Fujii Takehiro,Iizawa Yusuke,Kato Hiroyuki,Tanemura Akihiro,Kuriyama Naohisa,Azumi Yoshinori,Usui Masanobu,Sakurai Hiroyuki,Isaji Shuji

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference36 articles.

1. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study;Lancet Oncol,2014

2. Cancer statistics, 2017;CA Cancer J Clin,2017

3. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;N Engl J Med,2011

4. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;N Engl J Med,2013

5. Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 Trial;Ann Surg,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peritoneal washing cytology status as a crucial prognostic determinant in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection following preoperative chemoradiotherapy;PLOS ONE;2024-09-06

2. Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy – comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society;HPB;2023-10

3. Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy;PLOS ONE;2022-04-04

4. Pancreaticoduodenectomy with Splenic Artery Resection for Tumors of the Pancreatic Head and/or Body Invading the Splenic Artery;The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases;2022

5. Clinical significance and predictors of complete or near-complete histological response to preoperative chemoradiotherapy in patients with localized pancreatic ductal adenocarcinoma;Pancreatology;2021-12